Compositions described herein are purposed to attract gravid mosquitoes to oviposit in a preferred environment. The composition for directing the oviposition of mosquitoes comprises one or more attractants and NPK additive, wherein the NPK additive is mixture that contain chemical elements nitrogen, phosphorus and potassium. The attractants can be modified to provide a composition for facilitating the oviposition of different kind of mosquito. The composition described above, can be modified to provide a composition for facilitating the oviposition of the Anopheles species of Culicidae. The composition can also include cooked whey, n-heneicosane and/or tetradecanoic acid methyl ester to provide a composition for facilitating the oviposition of the Aedes species of Culicidae. The composition can also be modified to provide a composition for facilitating the oviposition of the Culex species of Culicidae.

Compositions described herein are purposed to attract gravid mosquitoes to oviposit in a preferred environment. The composition for directing the oviposition of mosquitoes comprises one or more attractants and NPK additive, wherein the NPK additive is mixture that contain chemical elements nitrogen, phosphorus and potassium. The attractants can be modified to provide a composition for facilitating the oviposition of different kind of mosquito. The composition described above, can be modified to provide a composition for facilitating the oviposition of the Anopheles species of Culicidae. The composition can also include cooked whey, n-heneicosane and/or tetradecanoic acid methyl ester to provide a composition for facilitating the oviposition of the Aedes species of Culicidae. The composition can also be modified to provide a composition for facilitating the oviposition of the Culex species of Culicidae.

The present invention provides methods of treating Restless Legs Syndrome (RLS) including administering to a subject an effective amount of a dopamine D.sub.1 receptor antagonist. Compositions and kits useful for treating RLS are also provided.

The present invention relates to an antimicrobial composition at the pH of the skin. Particularly, it relates to an antimicrobial composition comprising water soluble vinyl polymer, a carboxylic acid having pKa greater than 4.5; and an anionic surfactant, wherein the composition has pH in the range 4.5 to 6.5. The compositions provides synergistic antimicrobial effect in relatively shorter contact time. The invention further relates to a method of disinfecting a surface using the composition.

The present invention relates generally to peroxyformic acid forming compositions, methods for forming peroxyformic acid, preferably in situ, using the peroxyformic acid forming compositions. The present invention also relates to the peroxyformic acid formed by the above compositions and methods. The present invention further relates to the uses of the peroxyformic acid, preferably in situ, for treating a surface or a target. The present invention further relates to methods for treating a biofilm using peroxyformic acid, including peroxyformic acid generated in situ.

The present invention relates generally to peroxyformic acid forming compositions, methods for forming peroxyformic acid, preferably in situ, using the peroxyformic acid forming compositions. The present invention also relates to the peroxyformic acid formed by the above compositions and methods. The present invention further relates to the uses of the peroxyformic acid, preferably in situ, for treating a surface or a target. The present invention further relates to methods for treating a biofilm using peroxyformic acid, including peroxyformic acid generated in situ.

The present invention relates to novel sulfoperoxycarboxylic acid compounds, and methods for making and using them. The sulfoperoxycarboxylic compounds of the invention are storage stable, water soluble and have low to no odor. Further, the compounds of the present invention can be formed from non-petroleum based renewable materials. The compounds of the present invention can be used as antimicrobials, and bleaching agents. The compounds of the present invention are also suitable for use as coupling agents.

The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one further biological control agent selected from particular microorganisms disclosed herein and/or a mutant of a specific strain of a microorganism disclosed herein having all identifying characteristics of the respective strain, and/or at least one metabolite produced by the respective strain, and/or at least one metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.

The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or - unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Methods and compositions of attractants are described which provide vapor blends of citric acid, malic acid or tartaric acid and one or more compounds selected from the group consisting of isobutanol, racemic 2-methyl-1-butanol, S-()-2-methyl-1-butanol, 2-methyl-2-propanol, butyl butyrate, hexyl butyrate, heptyl butyrate, octyl butyrate and nonyl butyrate which function as highly effective attractants for yellowjacket wasps and other types of vespidae. By attracting wasps to traps or baits, the chemical attractants provide a means for detecting, surveying, monitoring, capturing, trapping and controlling the wasps.